NervGen Pharma(NGEN)
$1.88+0.25 (+15.34%)
NGEN
NervGen Pharma financials statements
$1.88
At close:+0.25 (+15.34%)
Want to see NGEN full AI Analyst Report?
NervGen Pharma (NGEN) Income Statement
141 Followers
NervGen Pharma Income Statement
Last quarter (Q2 2026), NervGen Pharma's total revenue was C$0.00. In Q2, NervGen Pharma's net income was C$-29.99M. See NervGen Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 0.00 | C$ -83.74K | C$ -145.01K | C$ -114.10K | C$ -42.95K | |
| C$ 25.08M | C$ 24.83M | C$ 17.63M | C$ 22.71M | C$ 12.87M | |
| Depreciation and Amortization | C$ 55.80K | C$ 83.74K | C$ 145.01K | C$ 114.10K | C$ 42.95K |
| C$ -5.65M | C$ -23.91M | C$ -22.24M | C$ -19.92M | C$ -12.78M | |
| C$ -25.08M | C$ -24.92M | C$ -17.78M | C$ -22.82M | C$ -12.91M | |
| C$ -19.04M | C$ 925.48K | ― | C$ 2.28M | C$ 85.29K | |
| C$ -44.12M | C$ -23.99M | C$ -22.38M | C$ -20.54M | C$ -12.82M | |
| C$ -44.12M | C$ -23.99M | C$ -22.38M | C$ -20.54M | C$ -12.82M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.61 | C$ -0.36 | C$ -0.37 | C$ -0.39 | C$ -0.33 |
| Diluted EPS | C$ -0.61 | C$ -0.36 | C$ -0.37 | C$ -0.39 | C$ -0.33 |
| Weighted Average Shares Outstanding | 72.33M | 67.32M | 59.29M | 52.65M | 39.29M |
| Weighted Average Shares Outstanding (Diluted) | 72.33M | 67.32M | 59.29M | 52.65M | 39.29M |
Currency in CAD
